This Biotech Veteran Is Using These Tips for Successful Drug Development, Here Is Why
Our second interview at Refresh in Vienna was with Peter Llewellyn-Davies, the founder of Accellerate…
February 14, 2018 - 5 minutes
Our second interview at Refresh in Vienna was with Peter Llewellyn-Davies, the founder of Accellerate…
Apeiron Biologics has been granted financing of €25M from the European Investment Bank (EIB) to…
Update (08/05/2017): The European Commission has granted marketing authorization to Apeiron Biologic's APN311 in the…
Classical music, the Danube, Schnitzel, and apple strüdel - a typical combination of Vienna. The…
Evotec had to announce a setback recently when its Alzheimer's treatment in collaboration with Roche…